For type 2 diabetes, GLP-1 receptor agonists are typically long-term therapies, similar to blood pressure or cholesterol medications
Nitric oxide signaling NO is a potent eryptosis suppressor (Fig
Common Side Effects According to IVY RX's published safety information, commonly reported side effects include nausea, vomiting, stomach upset, abdominal pain, constipation, diarrhea, heartburn, excessive belching and gas, dizziness, headaches, and fatigue
But as holistic therapists, we do want to offer a mental health perspective to keep in mind if youre thinking about starting a GLP-1
The first peptide polyagonist that was officially approved for T2DM and obesity was tirzepatide (LY3298176), a dual GLP-1/GIP receptor agonist which is currently under investigation in RCTs for obesity and NAFLD [7]
As individuals age, the capacity for glutathione synthesis naturally declines, creating a progressive deficit that may contribute to age-related cellular dysfunction and disease susceptibility